echoloc

Biodesix, Inc. Tech Stack

Lung disease diagnostics and biomarker development for oncology and primary care

Hospitals and Health Care Louisville, Colorado 201–500 employees Founded 2006 Public Company

Biodesix operates a diagnostics business focused on lung cancer and lung disease, paired with a development-services arm serving biopharma and research institutions. The stack reflects a clinical-diagnostics operation: mass spectrometry (LC-MS, MALDI-TOF, HPLC) for biomarker analysis, SQL Server + Python + Java for data pipelines, Salesforce + Power BI for commercial execution, and AWS infrastructure. The hiring mix is heavily skewed toward sales (19 of 25 open roles), with active projects centered on primary-care adoption and manufacturing efficiency—suggesting a push to scale a traditionally specialist diagnostic into routine clinical practice.

Tech Stack 29 technologies

Core StackPower BI Talend Apache NiFi Airbyte Informatica Python Java Salesforce AWS AWS RDS CloudWatch MySQL PostgreSQL Docker CRM DAX SQL Server Integration Services LIMS VPC IAM Apache HPLC LC-MS MALDI-TOF

What Biodesix, Inc. Is Building

Challenges

  • Low adoption of diagnostic products
  • Increasing market presence
  • Increasing product adoption in primary care
  • Process improvements for home phlebotomy
  • Market growth in primary care
  • Adopting diagnostic products in primary care
  • Ensuring fda cgmp compliance
  • Maintaining accurate inventory counts
  • Efficient kanban system operation
  • Analyzing market trends

Active Projects

  • Adoption of biodesix products in primary care
  • Strategic sales plans for market growth
  • Strategic sales plan development
  • Product improvement collaboration
  • Kit order and distribution system
  • Kanban system for manufacturing inventory
  • Lung disease test development
  • Product test realization
  • Process improvements for home phlebotomy
  • Kit stock management

Hiring Activity

Accelerating25 roles · 20 in 30d

Department

Sales
19
Research
2
Finance
1
Healthcare
1
Manufacturing
1
Operations
1

Seniority

Mid
10
Senior
8
Junior
4
Director
2
Manager
1

Notable leadership hires: Sales Director

Company intelligence

Find more companies like Biodesix, Inc. by tech stack, pain points and active projects

Get started free

About Biodesix, Inc.

Biodesix is a publicly traded (Nasdaq: BDSX) diagnostics company based in Louisville, Colorado, founded in 2006. The business spans two divisions: proprietary diagnostic tests (blood-based biomarkers for lung disease and cancer risk stratification) marketed to pulmonologists and oncologists, and development services that provide mass spectrometry, proteomics, and assay-development capabilities to external biopharma and research clients. The company operates manufacturing, distribution, and phlebotomy collection logistics to support test delivery. Current growth efforts center on expanding adoption beyond specialist referral networks into primary-care settings, where volumes remain constrained.

HeadquartersLouisville, Colorado
Company Size201–500 employees
Founded2006
Hiring MarketsUnited States

Frequently Asked Questions

What diagnostic tests does Biodesix offer?

Biodesix develops molecular diagnostics, biomarker tests, and companion diagnostics, primarily for lung cancer risk assessment and lung disease. The company also offers mass spectrometry analysis and development services to external biopharma and research institutions.

What is Biodesix's tech stack?

Clinical-grade instruments (LC-MS, MALDI-TOF, HPLC), lab information systems (LIMS), data pipelines (Python, Java, SQL Server, Talend, Apache NiFi, Airbyte), Salesforce CRM, Power BI analytics, and AWS cloud infrastructure (RDS, VPC, IAM, CloudWatch).

How this profile is built

Biodesix, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.